BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27629971)

  • 1. Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
    Ureshino H; Nishioka A; Kojima K; Kizuka H; Sano H; Shindo T; Kubota Y; Ando T; Kimura S
    Intern Med; 2016; 55(18):2703-6. PubMed ID: 27629971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
    Mustafa Ali MK; Sabha MM; Al-Rabi KH
    Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
    Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
    Patel SB; Gojo I; Tidwell ML; Sausville EA; Baer MR
    Leuk Lymphoma; 2011 Jul; 52(7):1211-4. PubMed ID: 21534873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
    Rousselot P; Coudé MM; Gokbuget N; Gambacorti Passerini C; Hayette S; Cayuela JM; Huguet F; Leguay T; Chevallier P; Salanoubat C; Bonmati C; Alexis M; Hunault M; Glaisner S; Agape P; Berthou C; Jourdan E; Fernandes J; Sutton L; Banos A; Reman O; Lioure B; Thomas X; Ifrah N; Lafage-Pochitaloff M; Bornand A; Morisset L; Robin V; Pfeifer H; Delannoy A; Ribera J; Bassan R; Delord M; Hoelzer D; Dombret H; Ottmann OG;
    Blood; 2016 Aug; 128(6):774-82. PubMed ID: 27121472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
    Takata H; Ikebe T; Sasaki H; Miyazaki Y; Ohtsuka E; Saburi Y; Ogata M; Shirao K
    Intern Med; 2016; 55(9):1177-81. PubMed ID: 27150875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
    Brattås MK; Reikvam H; Tvedt THA; Bruserud Ø
    Expert Opin Investig Drugs; 2019 May; 28(5):411-420. PubMed ID: 30916583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Yhim HY; Kim HS; Lee NR; Song EK; Kwak JY; Yim CY
    Int J Hematol; 2012 May; 95(5):585-7. PubMed ID: 22403059
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of patients with development of large granular lymphocyte expansion among dasatinib-treated patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplantation.
    Ito Y; Miyamoto T; Kamimura T; Aoki K; Henzan H; Aoki T; Shiratsuchi M; Kato K; Nagafuji K; Ogawa R; Eto T; Iwasaki H; Akashi K
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e47-54. PubMed ID: 25445469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.
    Prestes DP; Arbona E; Nevett-Fernandez A; Woolley AE; Ho VT; Koo S; Baden LR; Koreth J; Hammond SP; Issa NC; Marty FM
    Clin Infect Dis; 2017 Aug; 65(3):510-513. PubMed ID: 28419210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed methotrexate clearance and acute kidney injury after high-dose methotrexate chemotherapy concurrent with dasatinib in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report.
    Morota H; Saito S; Uchida E; Okura E; Matsuoka D; Hidaka Y; Natsume T; Watanabe T; Shigemura T; Morita D; Tanaka M; Kurata T; Sakashita K; Nakazawa Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28173. PubMed ID: 31925916
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracranial Hemorrhage Following Intrathecal Methotrexate Therapy for Acute Lymphoblastic Leukaemia.
    Purkait R; Dolai TK; Lath C; Das B
    Indian Pediatr; 2016 May; 53(5):423-4. PubMed ID: 27254055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful outcome of disseminated Candida tropicalis osteomyelitis on remission induction for childhood Philadelphia chromosome-positive acute lymphoblastic leukaemia-case report.
    Xie L; Long Q; Zhou G; Liu S; Wen FQ
    Ital J Pediatr; 2021 Feb; 47(1):27. PubMed ID: 33573668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia.
    Zhou KI; Lin C; Neff JL; Galal A
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37197831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection- and dasatinib-induced proteinuria in Ph+ALL.
    Kawaguchi H; Tamura Y; Suzuki S; Asano-Murakoshi T; Nonoyama S
    Pediatr Int; 2017 Jun; 59(6):740-741. PubMed ID: 28444835
    [No Abstract]   [Full Text] [Related]  

  • 17. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Aldoss I; Gaal K; Al Malki MM; Ali H; Nakamura R; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1900-1903. PubMed ID: 27346662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation.
    Vigna E; Gentile M; Giagnuolo G; Recchia AG; Bossio S; De Stefano L; Morelli R; Morabito F
    Leuk Lymphoma; 2016 Oct; 57(10):2445-7. PubMed ID: 26879289
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
    Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
    Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Roberts KE; Deininger MW; Hildebrandt GC; Gackenbach BK; Krem MM
    Leuk Lymphoma; 2020 Dec; 61(14):3507-3510. PubMed ID: 32835547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.